Schaefer R - Search Results

1

Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition.

Lorenzetti L, Dinh N, van der Straten A, Fonner V, Ridgeway K, Rodolph M, Schaefer R, Schmidt HA, Baggaley R. Lorenzetti L, et al. Among authors: schaefer r. J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26107. doi: 10.1002/jia2.26107. J Int AIDS Soc. 2023. PMID: 37439057 Free PMC article. Review.

2

Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.

Schaefer R, Schmidt HA, Ravasi G, Mozalevskis A, Rewari BB, Lule F, Yeboue K, Brink A, Mangadan Konath N, Sharma M, Seguy N, Hermez J, Alaama AS, Ishikawa N, Dongmo Nguimfack B, Low-Beer D, Baggaley R, Dalal S. Schaefer R, et al. Lancet HIV. 2021 Aug;8(8):e502-e510. doi: 10.1016/S2352-3018(21)00127-2. Epub 2021 Jul 12. Lancet HIV. 2021. PMID: 34265283 Free PMC article.

3

Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant data.

Schaefer R, Amparo da Costa Leite PH, Silva R, Abdool Karim Q, Akolo C, Cáceres CF, Dourado I, Green K, Hettema A, Hoornenborg E, Jana S, Kerschberger B, Mahler H, Matse S, McManus H, Molina JM, Reza-Paul S, Azwa I, Shahmanesh M, Taylor D, Vega-Ramirez H, Veloso VG, Baggaley R, Dalal S. Schaefer R, et al. Lancet HIV. 2022 Apr;9(4):e242-e253. doi: 10.1016/S2352-3018(22)00004-2. Epub 2022 Mar 7. Lancet HIV. 2022. PMID: 35271825 Free PMC article.

4

Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job?

Schmidt HA, Schaefer R, Nguyen VTT, Radebe M, Sued O, Rodolph M, Ford N, Baggaley R. Schmidt HA, et al. Among authors: schaefer r. Lancet HIV. 2022 May;9(5):e363-e366. doi: 10.1016/S2352-3018(22)00006-6. Epub 2022 Mar 28. Lancet HIV. 2022. PMID: 35358418 Free PMC article. Review.

5

Realising the potential of risk-informed PrEP.

Schaefer R, Schmidt HA. Schaefer R, et al. Lancet HIV. 2022 May;9(5):e302-e304. doi: 10.1016/S2352-3018(22)00104-7. Lancet HIV. 2022. PMID: 35489374 No abstract available.

6

Long-acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice.

Schmidt HA, Rodolph M, Schaefer R, Baggaley R, Doherty M. Schmidt HA, et al. Among authors: schaefer r. J Int AIDS Soc. 2022 Jul;25(7):e25963. doi: 10.1002/jia2.25963. J Int AIDS Soc. 2022. PMID: 35903882 Free PMC article. No abstract available.

7

Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis.

Ahluwalia AK, Inzaule S, Baggaley RC, Vitoria M, Schaefer R, Schmidt HA, Rodolph M, Giron A, Jordan MR. Ahluwalia AK, et al. Among authors: schaefer r. AIDS. 2022 Nov 1;36(13):1897-1898. doi: 10.1097/QAD.0000000000003322. AIDS. 2022. PMID: 36172874 Free PMC article. No abstract available.

8

HIV PrEP and viral hepatitis: a unique opportunity for integration.

Schaefer R, Schmidt HA, Rodolph M, Lesi O, Baggaley R, Luhmann N. Schaefer R, et al. Lancet HIV. 2022 Nov;9(11):e745. doi: 10.1016/S2352-3018(22)00297-1. Lancet HIV. 2022. PMID: 36332650 No abstract available.

9

Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition.

Fonner VA, Ridgeway K, van der Straten A, Lorenzetti L, Dinh N, Rodolph M, Schaefer R, Schmidt HA, Nguyen VTT, Radebe M, Peralta H, Baggaley R. Fonner VA, et al. Among authors: schaefer r. AIDS. 2023 May 1;37(6):957-966. doi: 10.1097/QAD.0000000000003494. Epub 2023 Jan 25. AIDS. 2023. PMID: 36723489 Free PMC article.

10

Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.

Shaw G, Schaefer R, Schmidt HA, Madden A, Chang J, Mozalevskis A, Msimanga-Radebe B, Mangadan Konath N, Verster A, Baggaley R, Rodolph M, Macdonald V. Shaw G, et al. Among authors: schaefer r. Harm Reduct J. 2023 Feb 13;20(1):16. doi: 10.1186/s12954-023-00729-6. Harm Reduct J. 2023. PMID: 36782321 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

768 results

Search Page